If you need more lookups,
subscriptions start at $34 USD/month.
Stephen Hull Location
Washington, DC, US
Stephen Hull Work
Sr. Director, Clinical Development @ (March 2026 - Present)
Medical Director, Tumor Agnostic GI and GU @ (May 2024 - February 2026)
Medical Science Liaison, Radioligand Therapy (RLT) @ (January 2020 - May 2024)
Senior Medical Science Liaison @ Phaidon Global Company (PGC) (June 2019 - January 2020)
Medical Science Liaison (Contract MSL - Syneos Health), Medical Affairs @ (August 2018 - May 2019)
Medical Science Liaison (Contract MSL - BestMSLs), Medical Affairs @ (February 2018 - August 2018)
Regional Medical Director (RMD, Sr. MSL), Clinical Medical Affairs @ CardioDx (February 2017 - January 2018)
Regional Medical Manager (RMM, MSL), Medical Affairs @ Supernus Pharmaceuticals, Inc. (May 2016 - February 2017)
Clinical Science Liaison (CSL, MSL), Medical Affairs @ (January 2015 - January 2016)
Stephen Hull Education
American Public University
Master of Business Administration - MBA
2020-2022
American University of the Caribbean
Doctor of Medicine - MD
University of Virginia
Bachelor of Science (B.Sc.) (Biology)
Stephen Hull Skills
Advisory Boards
Biomarker Discovery
Biotechnology
Business Acumen
Business Development
Clinical Data
Clinical Development
Clinical Operations
Clinical Research
Clinical Trials
Content Development
Cross-functional Collaborations
Cross-functional Team Leadership
Data Presentation
Development Strategy
Drug Development
Drug Safety
Education
Education Strategy
Epidemiology
Genomics
Healthcare Management
Hematology
Internal & External Communications
Interpersonal Communication
Key Opinion Leaders
Key Performance Indicators
Leadership
Managed Care Organizations
Market Access
Medical Affairs
Medical Devices
Medical Education
Medical Information
Medical Science Liaison
Oncology
Oncology Clinical Research
Pharmaceutical and Therapeutic (P&T) Committees
Presentation Skills
Product Launch
Product Strategy
Promotional Review Committee (PRC)
Public Speaking
Real World Evidence (RWE)
Regulatory Affairs
Scientific Review
Strategic Communications
Strategic Initiatives
Strategic Partnerships
Strategic Planning
Medical Writing
Ich Gcp
Allergy
Promotional Review Committee Prc
Cardiology
Neuroscience
Gastroenterology
Neurology
Infectious Diseases
Pulmonology
Immunology
Healthcare
Pharmaceutical And Therapeutic P&T Committees
Life Sciences
Pharmacovigilance
Asthma
Medicine
Pharmaceutics
HCV
Managed Care
Electronic Medical Records
Endocrinology
Diabetes
Pediatrics
Research
Pharmaceutical Industry
Rheumatology
Healthcare Industry
FDA
HIV
Pharmaceutical and Therapeutic Committees
Promotional Review Committee
Multiple Sclerosis
Stephen Hull Summary
Stephen Hull, based in Washington, DC, US, is currently a Sr. Director, Clinical Development at Alpha-9 Oncology. Stephen Hull brings experience from previous roles at AstraZeneca, Novartis, Phaidon Global Company (PGC) and Genentech. Stephen Hull holds a 2020 - 2022 Master of Business Administration - MBA @ American Public University. With a robust skill set that includes Advisory Boards, Biomarker Discovery, Biotechnology, Business Acumen, Business Development and more. Stephen Hull has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Stephen Hull?
Find contact details for 700 million professionals.